Innate Immune Responses to Wildtype and Attenuated Sheeppox Virus Mediated Through RIG-1 Sensing in PBMC In-Vitro
Sheeppox (SPP) is a highly contagious disease of small ruminants caused by sheeppox virus (SPPV) and predominantly occurs in Asia and Africa with significant economic losses. SPPV is genetically and immunologically closely related to goatpox virus (GTPV) and lumpy skin disease virus (LSDV), which in...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.666543/full |
id |
doaj-1023c7c0980e4e60924d5cc1ae91f144 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tesfaye Rufael Chibssa Tesfaye Rufael Chibssa Tesfaye Rufael Chibssa Richard Thiga Kangethe Francisco J. Berguido Tirumala Bharani K. Settypalli Yang Liu Reingard Grabherr Angelika Loitsch Elena Lucia Sassu Elena Lucia Sassu Rudolf Pichler Giovanni Cattoli Adama Diallo Adama Diallo Viskam Wijewardana Charles Euloge Lamien |
spellingShingle |
Tesfaye Rufael Chibssa Tesfaye Rufael Chibssa Tesfaye Rufael Chibssa Richard Thiga Kangethe Francisco J. Berguido Tirumala Bharani K. Settypalli Yang Liu Reingard Grabherr Angelika Loitsch Elena Lucia Sassu Elena Lucia Sassu Rudolf Pichler Giovanni Cattoli Adama Diallo Adama Diallo Viskam Wijewardana Charles Euloge Lamien Innate Immune Responses to Wildtype and Attenuated Sheeppox Virus Mediated Through RIG-1 Sensing in PBMC In-Vitro Frontiers in Immunology gene expression PRRs cytokine RIG-1 LAV SPPV |
author_facet |
Tesfaye Rufael Chibssa Tesfaye Rufael Chibssa Tesfaye Rufael Chibssa Richard Thiga Kangethe Francisco J. Berguido Tirumala Bharani K. Settypalli Yang Liu Reingard Grabherr Angelika Loitsch Elena Lucia Sassu Elena Lucia Sassu Rudolf Pichler Giovanni Cattoli Adama Diallo Adama Diallo Viskam Wijewardana Charles Euloge Lamien |
author_sort |
Tesfaye Rufael Chibssa |
title |
Innate Immune Responses to Wildtype and Attenuated Sheeppox Virus Mediated Through RIG-1 Sensing in PBMC In-Vitro |
title_short |
Innate Immune Responses to Wildtype and Attenuated Sheeppox Virus Mediated Through RIG-1 Sensing in PBMC In-Vitro |
title_full |
Innate Immune Responses to Wildtype and Attenuated Sheeppox Virus Mediated Through RIG-1 Sensing in PBMC In-Vitro |
title_fullStr |
Innate Immune Responses to Wildtype and Attenuated Sheeppox Virus Mediated Through RIG-1 Sensing in PBMC In-Vitro |
title_full_unstemmed |
Innate Immune Responses to Wildtype and Attenuated Sheeppox Virus Mediated Through RIG-1 Sensing in PBMC In-Vitro |
title_sort |
innate immune responses to wildtype and attenuated sheeppox virus mediated through rig-1 sensing in pbmc in-vitro |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2021-06-01 |
description |
Sheeppox (SPP) is a highly contagious disease of small ruminants caused by sheeppox virus (SPPV) and predominantly occurs in Asia and Africa with significant economic losses. SPPV is genetically and immunologically closely related to goatpox virus (GTPV) and lumpy skin disease virus (LSDV), which infect goats and cattle respectively. SPPV live attenuated vaccines (LAVs) are used for vaccination against SPP and goatpox (GTP). Mechanisms related to innate immunity elicited by SPPV are unknown. Although adaptive immunity is responsible for long-term immunity, it is the innate responses that prevent viral invasion and replication before LAVs generate specific long-term protection. We analyzed the relative expression of thirteen selected genes that included pattern recognition receptors (PRRs), Nuclear factor-κβ p65 (NF-κβ), and cytokines to understand better the interaction between SPPV and its host. The transcripts of targeted genes in sheep PBMC incubated with either wild type (WT) or LAV SPPV were analyzed using quantitative PCR. Among PRRs, we observed a significantly higher expression of RIG-1 in PBMC incubated with both WT and LAV, with the former producing the highest expression level. However, there was high inter-individual variability in cytokine transcripts levels among different donors, with the expression of TNFα, IL-15, and IL-10 all significantly higher in both PBMC infected with either WT or LAV compared to control PBMC. Correlation studies revealed a strong significant correlation between RIG-1 and IL-10, between TLR4, TNFα, and NF-κβ, between IL-18 and IL-15, and between NF-κβ and IL-10. There was also a significant negative correlation between RIG-1 and IFNγ, between TLR3 and IL-1 β, and between TLR4 and IL-15 (P< 0.05). This study identified RIG-1 as an important PRR in the signaling pathway of innate immune activation during SPPV infection, possibly through intermediate viral dsRNA. The role of immunomodulatory molecules produced by SPPV capable of inhibiting downstream signaling activation following RIG-1 upregulation is discussed. These findings advance our knowledge of the induction of immune responses by SPPV and will help develop safer and more potent vaccines against SPP and GTP. |
topic |
gene expression PRRs cytokine RIG-1 LAV SPPV |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2021.666543/full |
work_keys_str_mv |
AT tesfayerufaelchibssa innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT tesfayerufaelchibssa innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT tesfayerufaelchibssa innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT richardthigakangethe innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT franciscojberguido innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT tirumalabharaniksettypalli innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT yangliu innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT reingardgrabherr innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT angelikaloitsch innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT elenaluciasassu innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT elenaluciasassu innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT rudolfpichler innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT giovannicattoli innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT adamadiallo innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT adamadiallo innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT viskamwijewardana innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro AT charleseulogelamien innateimmuneresponsestowildtypeandattenuatedsheeppoxvirusmediatedthroughrig1sensinginpbmcinvitro |
_version_ |
1721375890064015360 |
spelling |
doaj-1023c7c0980e4e60924d5cc1ae91f1442021-06-15T15:02:10ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-06-011210.3389/fimmu.2021.666543666543Innate Immune Responses to Wildtype and Attenuated Sheeppox Virus Mediated Through RIG-1 Sensing in PBMC In-VitroTesfaye Rufael Chibssa0Tesfaye Rufael Chibssa1Tesfaye Rufael Chibssa2Richard Thiga Kangethe3Francisco J. Berguido4Tirumala Bharani K. Settypalli5Yang Liu6Reingard Grabherr7Angelika Loitsch8Elena Lucia Sassu9Elena Lucia Sassu10Rudolf Pichler11Giovanni Cattoli12Adama Diallo13Adama Diallo14Viskam Wijewardana15Charles Euloge Lamien16Animal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology Laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, AustriaInstitute of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, AustriaNational Animal Health Diagnostic and Investigation Center (NAHDIC), Sebeta, EthiopiaAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology Laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, AustriaAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology Laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, AustriaAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology Laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, AustriaChina National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaInstitute of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, AustriaAustrian Agency for Health and Food Safety (AGES), Vienna, AustriaAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology Laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, AustriaDepartment for Farm Animals and Veterinary Public Health, University Clinic for Swine, University of Veterinary Medicine, Vienna, AustriaAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology Laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, AustriaAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology Laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, AustriaLaboratoire National d’Elevage et de Recherches Vétérinaires, Institut Sénégalais de Recherches Agricoles (ISRA), Dakar, SénégalUMR CIRAD INRA, Animal, Santé, Territoires, Risques et Ecosystèmes (ASTRE), Montpellier, FranceAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology Laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, AustriaAnimal Production and Health Laboratory, Joint FAO/IAEA Agricultural and Biotechnology Laboratory, Division of Nuclear Techniques in Food and Agriculture, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, AustriaSheeppox (SPP) is a highly contagious disease of small ruminants caused by sheeppox virus (SPPV) and predominantly occurs in Asia and Africa with significant economic losses. SPPV is genetically and immunologically closely related to goatpox virus (GTPV) and lumpy skin disease virus (LSDV), which infect goats and cattle respectively. SPPV live attenuated vaccines (LAVs) are used for vaccination against SPP and goatpox (GTP). Mechanisms related to innate immunity elicited by SPPV are unknown. Although adaptive immunity is responsible for long-term immunity, it is the innate responses that prevent viral invasion and replication before LAVs generate specific long-term protection. We analyzed the relative expression of thirteen selected genes that included pattern recognition receptors (PRRs), Nuclear factor-κβ p65 (NF-κβ), and cytokines to understand better the interaction between SPPV and its host. The transcripts of targeted genes in sheep PBMC incubated with either wild type (WT) or LAV SPPV were analyzed using quantitative PCR. Among PRRs, we observed a significantly higher expression of RIG-1 in PBMC incubated with both WT and LAV, with the former producing the highest expression level. However, there was high inter-individual variability in cytokine transcripts levels among different donors, with the expression of TNFα, IL-15, and IL-10 all significantly higher in both PBMC infected with either WT or LAV compared to control PBMC. Correlation studies revealed a strong significant correlation between RIG-1 and IL-10, between TLR4, TNFα, and NF-κβ, between IL-18 and IL-15, and between NF-κβ and IL-10. There was also a significant negative correlation between RIG-1 and IFNγ, between TLR3 and IL-1 β, and between TLR4 and IL-15 (P< 0.05). This study identified RIG-1 as an important PRR in the signaling pathway of innate immune activation during SPPV infection, possibly through intermediate viral dsRNA. The role of immunomodulatory molecules produced by SPPV capable of inhibiting downstream signaling activation following RIG-1 upregulation is discussed. These findings advance our knowledge of the induction of immune responses by SPPV and will help develop safer and more potent vaccines against SPP and GTP.https://www.frontiersin.org/articles/10.3389/fimmu.2021.666543/fullgene expressionPRRscytokineRIG-1LAVSPPV |